R T P Poon
Overview
Explore the profile of R T P Poon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
595
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ng K, Chok K, Chan A, Cheung T, Wong T, Fung J, et al.
Br J Surg
. 2017 Nov;
104(13):1775-1784.
PMID: 29091283
Background: Hepatic resection and radiofrequency ablation (RFA) are treatment options for early-stage hepatocellular carcinoma (HCC). Whether tumour recurrence and long-term survival favour either treatment has not been established. This randomized...
2.
Cheung T, Poon R, Chan A, Lo C
J Gastroenterol Hepatol
. 2014 Aug;
29(9):1663.
PMID: 25154444
No abstract available.
3.
Cheung T, Ip E, Poon R, Trendell-Smith N
Hong Kong Med J
. 2013 Oct;
19(5):460.e1-2.
PMID: 24088597
No abstract available.
4.
Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma
Fatima S, Lee N, Tsang F, Kolligs F, Ng I, Poon R, et al.
Oncogene
. 2012 Jan;
31(38):4233-44.
PMID: 22249261
Deregulation of Wnt/β-catenin pathway is a hallmark of major gastrointestinal cancers including hepatocellular carcinoma (HCC). The oncogenic role of β-catenin is well defined but reasons for its accumulation in HCC...
5.
Fan S, Poon R, Yeung C, Lam C, Lo C, Yuen W, et al.
Br J Surg
. 2011 Jun;
98(9):1292-300.
PMID: 21656513
Background: There is a trend to offer liver transplantation to patients with hepatocellular carcinoma (HCC) with tumour status within the Milan criteria but with preserved liver function. This study aimed...
6.
Lu W, Lee N, Kaul S, Lan F, Poon R, Wadhwa R, et al.
Cell Death Differ
. 2011 Jan;
18(6):1046-56.
PMID: 21233847
Stress protein mortalin is a multifunctional protein and is highly expressed in cancers. It has been shown to interact with tumor suppressor protein-p53 (both wild and mutant types) and inactivates...
7.
Cheng Q, Ng K, Fan S, Lim Z, Guo D, Liu X, et al.
Am J Transplant
. 2010 Apr;
10(5):1178-88.
PMID: 20420630
In this study, we aimed to investigate the significance of hepatic stellate cells (HSCs) activation in small-for-size fatty liver graft injury and to explore the underlying molecular mechanism in a...
8.
Cheung K, Ye D, Yang Z, Lu L, Liu C, Wang X, et al.
J Ethnopharmacol
. 2009 Jun;
124(1):142-50.
PMID: 19501992
Background/aims: Hepatic fibrosis is a consequence of severe liver damage that occurs in many patients with chronic liver diseases. TCM 319 recipe is a Chinese Medicine formula which consists of...
9.
Lam T, Wong G, Chong H, Cheng P, Choi S, Chow T, et al.
Cancer Lett
. 2009 Jan;
277(1):91-100.
PMID: 19138817
Human hepatocellular carcinoma (HCC) has an elevated requirement for arginine in vitro, and pegylated recombinant human arginase I (rhArg-PEG), an arginine-depleting enzyme, can inhibit the growth of arginine-dependent tumors. While...
10.
Sun C, Ng K, Sun B, Ho J, Lee T, Ng I, et al.
Br J Cancer
. 2007 Jun;
97(1):50-7.
PMID: 17551499
Understanding the precise molecular mechanisms that trigger liver cancer cell migration and invasion could develop novel therapeutic strategies targeting cancer cell invasion to increase the sensitivity to current treatment modalities....